Hong Kong Stock Movement | LENS (06613) Soars Over 7% as Strong Brain Tech Confirms Completion of Approximately 2 Billion Yuan Funding Round; Company Exclusively Handles Mass Production of Its Core Hardware Modules

Stock News01-09

LENS (06613) surged more than 5% again. As of the time of writing, the stock was up 6.28% at HKD 28.08, with a turnover of HKD 158 million. Recent media reports indicated that Strong Brain Tech, one of the "Hangzhou Six Little Dragons," has completed a funding round of approximately 2 billion yuan, setting the record for the second-largest funding in the global brain-computer interface field outside of Neuralink. On January 8, Strong Brain Tech stated, "The funding has indeed been completed; please refer to the company's official release for specific details. The raised funds will be used to fully accelerate the R&D of core brain-computer interface technologies, achieve breakthrough engineering feats, and scale up product manufacturing and mass production." LENS previously indicated on an investor interaction platform that it is a strategic investor in Strong Brain Tech and has exclusively undertaken the mass production of Strong Brain Tech's core hardware modules. In November 2025, LENS and Strong Brain Tech jointly donated a large batch of intelligent bionic limbs to the Hunan Provincial Disabled Persons' Federation, with the core modules all sourced from LENS's production lines. Simultaneously, the company has maintained an in-depth collaboration with a major North American client for over 10 years, serving as a Tier 1 core supplier. Leveraging the mass production experience accumulated from projects like Strong Brain Tech and its strong precision manufacturing capabilities, the company is actively pursuing further cooperation opportunities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment